Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Axsome Therapeutics Inc’s current trading price is -15.91% away from its 52-week high, while its distance from the 52-week low is 54.83%. The stock’s price range over this period has fluctuated between $75.56 and $139.13. The company, operating within the financial sector, had a trading volume of approximately 0.66 million for the day, which was noticeably higher than the average daily share volume of 0.63 million over the last 3 months.
At present, Axsome Therapeutics Inc (AXSM) has a stock price of $116.99. In the previous session, the stock saw a rise, peaking at $200.0 after an opening price of $116.99. The day’s lowest price was $144.0, and it closed at $111.29.
Axsome Therapeutics Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $139.13 on 02/21/25, while the lowest price for the same duration was marked at $75.56 on 12/30/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Axsome Therapeutics Inc (AXSM) has experienced a quarterly rise of 7.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.84B and boasts a workforce of 683 employees.
Axsome Therapeutics Inc: What Analysts Are Saying
As of right now, 14 analysts are rating Axsome Therapeutics Inc as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 106.47, with a change in price of -4.78. Similarly, Axsome Therapeutics Inc recorded 689,090 in trading volume during the last 100 days, posting a change of -3.93%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AXSM stands at 3.06. Similarly, the long-term debt-to-equity ratio is also 1.98.
AXSM Stock Stochastic Average
Today, Axsome Therapeutics Inc’s raw stochastic average for the past 50 days stands at 99.33%, indicating a rise from the raw stochastic average of the last 20 days, which was 99.33%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 94.65% and 86.43% respectively.
AXSM Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 35.77%.However, over the last six months, we can see a stronger performance of -7.85%. Over the last 30 days, the price of AXSM has fallen by 14.08%. And in the last five days, it has surged by 6.95%.
